Aligos Therapeutics, Inc.
ALGS
Revenue
169.00k
▼-572.00k▼-77.19%
3 Months ChangeAssets
88.53M
▼-21.23M▼-19.34%
3 Months ChangeLiabilities
34.99M
▼-2.94M▼-7.76%
3 Months ChangeFree Cash Flow
-22.39M
▼-1.45M▼-6.90%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-03-05
Form 8-K
ID: 0001171843-26-001340
2026-02-04
Form 8-K
ID: 0001193125-26-037558
2025-11-06
Form 10-Q
ID: 0001193125-25-268203
2025-11-06
Form 8-K
ID: 0001171843-25-007075
2025-08-06
Form 10-Q
ID: 0000950170-25-104042
2025-08-06
Form 8-K
ID: 0001171843-25-005116
2025-06-26
Form 8-K
ID: 0001193125-25-148905
2025-05-06
Form 10-Q
ID: 0000950170-25-063983
2025-05-06
Form 8-K
ID: 0001171843-25-002781
2025-03-10
Form 8-K
ID: 0001171843-25-001352